Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR).
James F, Goh MSY, Mouhtouris E, Vogrin S, Chua KYL, Holmes NE, Awad A, Copaescu AM, De Luca JF, Zubrinich C, Gin D, Cleland H, Douglas A, Kern JS, Katelaris CH, Thien F, Barnes S, Yun J, Tong W, Smith WB, Carr A, Anderson T, Legg A, Bourke J, Mackay LK, Aung AK, Phillips EJ, Trubiano J.
James F, et al. Among authors: barnes s.
BMJ Open. 2022 Aug 17;12(8):e055906. doi: 10.1136/bmjopen-2021-055906.
BMJ Open. 2022.
PMID: 35977774
Free PMC article.
In this Australasian, multicentre, prospective registry, we plan to examine the clinical presentation, drug causality, genomic predictors, potential diagnostic approaches, treatments and long-term outcomes of SCAR in Australia and New Zealand. METHODS AND ANALYSIS: Adult a …
In this Australasian, multicentre, prospective registry, we plan to examine the clinical presentation, drug causality, genomic predictors, p …